Authorized generics and first-to-file generics both lower drug costs, but authorized generics drive prices down further by adding competition during the first-filer's exclusivity period - saving patients and insurers millions.
Authorized generics and first-to-file generics both lower drug costs, but authorized generics drive prices down further by adding competition during the first-filer's exclusivity period - saving patients and insurers millions.